Found: 13
Select item for more details and to access through your institution.
Mobilization of Bone Marrow-Derived Hematopoietic and Endothelial Stem Cells After Orthotopic Liver Transplantation and Liver Resection.
- Published in:
- Stem Cells, 2006, v. 24, n. 12, p. 2817, doi. 10.1634/stemcells.2006-0333
- By:
- Publication type:
- Article
Isolation of Multipotent Neural Crest-Derived Stem Cells from the Adult Mouse Cornea.
- Published in:
- Stem Cells, 2006, v. 24, n. 12, p. 2714, doi. 10.1634/stemcells.2006-0333
- By:
- Publication type:
- Article
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45000-z
- By:
- Publication type:
- Article
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 9, p. 1271, doi. 10.1007/s00277-013-1757-6
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis", caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e78, doi. 10.1016/j.clml.2019.09.125
- By:
- Publication type:
- Article
A Maturation Index defines Newly Diagnosed Multiple Myeloma Patients with advanced immunophenotypic and Molecular Differentiation profiles associated with poor prognosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e69, doi. 10.1016/j.clml.2019.09.110
- By:
- Publication type:
- Article
Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e12, doi. 10.1016/j.clml.2017.03.020
- By:
- Publication type:
- Article
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
- Published in:
- Genes, Chromosomes & Cancer, 2016, v. 55, n. 4, p. 375, doi. 10.1002/gcc.22341
- By:
- Publication type:
- Article
A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 41, doi. 10.1002/hon.2820
- By:
- Publication type:
- Article
FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. E14, doi. 10.1002/ajh.24276
- By:
- Publication type:
- Article
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 647, doi. 10.1002/ajh.24035
- By:
- Publication type:
- Article